Table 2.

Distribution of pDCs in Tissues During Steady State

Tissue	Human	Mice
Secondary lymphoid organs
Thymus	+ (Olweus et al. 1997 Bendriss-Vermare et al. 2001) (Martin-Gayo et al. 2010)	+ (Martin et al. 2002) (Asselin-Paturel et al. 2003) (Blasius et al. 2004) (Omatsu et al. 2005)
Spleen	+ (Velasquez-Lopera et al. 2008) (Boor et al. 2019)	+ (Asselin-Paturel et al. 2001) (Nakano et al. 2001) (Martin et al. 2002) (Asselin-Paturel et al. 2003) (Blasius et al. 2004) (Omatsu et al. 2005)
Liver	+ (Pedroza-Gonzalez et al. 2015)* (Boor et al. 2019)	+ (Blasius et al. 2004) (Omatsu et al. 2005)
Lymph nodes	+ (Olweus et al. 1997) (Tanis et al. 2004) (Boor et al. 2019)	+ (Nakano et al. 2001) (Martin et al. 2002) (Asselin-Paturel et al. 2003) (Blasius et al. 2004)
Tonsils	+ (Grouard et al. 1997) (Olweus et al. 1997)	N/A
Peyer’s patches	+ (Jameson et al. 2002)	+ (Castellaneta et al. 2004) (Contractor et al. 2007)
Peripheral Tissues
Lung	+ (Demedts et al. 2005) (Baharom et al. 2017)	+ (de Heer et al. 2004) (Omatsu et al. 2005) (Venet et al. 2010)
Kidney	+ (Woltman et al. 2007)	+ (Coates et al. 2004)
Vagina	N/E	+ (Lund et al. 2006)
Cervix	+ (Agrawal et al. 2009)	N/E

N/A: Not applicable

N/E: Not evaluated

^*In patients with hepatic tumors, in sample distant from tumor (at least 1 cm)